Romana Idress
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Romana Idress has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Usman Tariq
Histopathology, Prince Faisal Cancer Centre, King Fahd Specialist Hospital, Buraydah, SAU
4 shared publications Naila Kayani
Aga Khan University Hospital
4 shared publications- Zubair Ahmad
Department of Statistics, Quaid-i-Azam University, Islamabad 44000, Pakistan
4 shared publications - Lubna Mushtaque Vohra
Surgery, Aga Khan University, Karachi, Pakistan
3 shared publications Nasir Ud Din
Aga Khan University Hospital
3 shared publications- Nasir Ud Din
Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan
3 shared publications
Latest Publications
- 24 September 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
Clinicopathological Features of Mammary Myofibroblastoma: A Single Institution Case Series
Mammary myofibroblastoma (MFB) is a rare benign mesenchymal tumor of the breast with myofibroblastic differentiation. Its diverse morphological spectrum may pose diagnostic challenges, particularly in limited biopsy specimens. All MFB patients diagnosed at a tertiary care center between 2015 and 2024 were reviewed retrospectively. Eleven patients were identified, including 7 women and 4 men, with a mean age of 56.5 years (range: 31-75 years). All patients presented with a solitary, painless breast mass. Tumor size ranged from 2.3 to 14 cm. Histologically, 9 tumors showed spindle cell morphology, whereas 2 showed epithelioid features. The common findings included short intersecting fascicles of bland spindle cells, variable collagen deposition, ectatic blood vessels, and focal adipocytic components. Immunohistochemically, CD34 was positive in 9 tumors, desmin in 8, smooth muscle actin (ACTA2) in 5, BCL2 and CD99 in 7 each, and CD10 in 4 tumors. Keratin AE1/AE3, p63, S100, and STAT6 were negative in all tumors. Follow-up data was available in 9 patients and no recurrence was reported. Recognition of its characteristic morphological and immunohistochemical features is essential to avoid diagnostic pitfalls. Complete surgical excision is curative, with an excellent prognosis.
- 24 September 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
Clinicopathological Features of Mammary Myofibroblastoma: A Single Institution Case Series
Mammary myofibroblastoma (MFB) is a rare benign mesenchymal tumor of the breast with myofibroblastic differentiation. Its diverse morphological spectrum may pose diagnostic challenges, particularly in limited biopsy specimens. All MFB patients diagnosed at a tertiary care center between 2015 and 2024 were reviewed retrospectively. Eleven patients were identified, including 7 women and 4 men, with a mean age of 56.5 years (range: 31-75 years). All patients presented with a solitary, painless breast mass. Tumor size ranged from 2.3 to 14 cm. Histologically, 9 tumors showed spindle cell morphology, whereas 2 showed epithelioid features. The common findings included short intersecting fascicles of bland spindle cells, variable collagen deposition, ectatic blood vessels, and focal adipocytic components. Immunohistochemically, CD34 was positive in 9 tumors, desmin in 8, smooth muscle actin (ACTA2) in 5, BCL2 and CD99 in 7 each, and CD10 in 4 tumors. Keratin AE1/AE3, p63, S100, and STAT6 were negative in all tumors. Follow-up data was available in 9 patients and no recurrence was reported. Recognition of its characteristic morphological and immunohistochemical features is essential to avoid diagnostic pitfalls. Complete surgical excision is curative, with an excellent prognosis.
- 6 June 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34  (8) , 1980-1989
Fibromatosis-Like Metaplastic Carcinoma of Breast: A Clinicopathological Study of 6 Patients
Fibromatosis-like metaplastic carcinoma (FLMC) of breast is a rare neoplasm that exhibits distinct low-grade cytomorphology, a tendency for local recurrence and a favorable prognosis. This retrospective study aimed to evaluate the clinicopathological and immunohistochemical features of FLMC and assess its clinical behavior. Six female patients with histologically confirmed FLMC were included. Hematoxylin and eosin-stained slides were reviewed, and immunohistochemistry for keratin AE1/AE3, keratin CAM5.2, keratin 5/6, p63, EMA, ACTA1, desmin, and CD34 was performed. The mean age was 57.3 years, and all patients presented with a painless breast mass. Tumors were firm, unencapsulated, and averaged 4.9 cm in size on gross examination. Microscopically, they showed bland spindle cells in fascicular and storiform patterns with infiltrative borders. All tumors were positive for keratin AE1/AE3, keratin CAM5.2, and p63. EMA was positive in 1/3 tumors, keratin 5/6 in 3/3, ACTA1 in 2/3. All tumors were negative for desmin and CD34. No nodal metastasis was identified. On follow-up, one patient developed bone metastasis after 2 years, while the others remained disease-free 3 years post-surgery. FLMC is a rare low-grade epithelial malignancy that can mimic benign spindle cell lesions, making immunohistochemistry essential for diagnosis. Complete surgical excision with clear margins is curative in most patients.
- 6 June 2026
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34  (8) , 1980-1989
Fibromatosis-Like Metaplastic Carcinoma of Breast: A Clinicopathological Study of 6 Patients
Fibromatosis-like metaplastic carcinoma (FLMC) of breast is a rare neoplasm that exhibits distinct low-grade cytomorphology, a tendency for local recurrence and a favorable prognosis. This retrospective study aimed to evaluate the clinicopathological and immunohistochemical features of FLMC and assess its clinical behavior. Six female patients with histologically confirmed FLMC were included. Hematoxylin and eosin-stained slides were reviewed, and immunohistochemistry for keratin AE1/AE3, keratin CAM5.2, keratin 5/6, p63, EMA, ACTA1, desmin, and CD34 was performed. The mean age was 57.3 years, and all patients presented with a painless breast mass. Tumors were firm, unencapsulated, and averaged 4.9 cm in size on gross examination. Microscopically, they showed bland spindle cells in fascicular and storiform patterns with infiltrative borders. All tumors were positive for keratin AE1/AE3, keratin CAM5.2, and p63. EMA was positive in 1/3 tumors, keratin 5/6 in 3/3, ACTA1 in 2/3. All tumors were negative for desmin and CD34. No nodal metastasis was identified. On follow-up, one patient developed bone metastasis after 2 years, while the others remained disease-free 3 years post-surgery. FLMC is a rare low-grade epithelial malignancy that can mimic benign spindle cell lesions, making immunohistochemistry essential for diagnosis. Complete surgical excision with clear margins is curative in most patients.
- Open Access
- 2 January 2025
- Published by Springer Nature in Cureus
- Vol. 17  (1) , e76786
Dermatofibrosarcoma Protuberans of the Breast: A Clinicopathological Study of a Rare Cutaneous Low-Grade Sarcoma
Background: Dermatofibrosarcoma protuberans (DFSP) of the breast is a rare entity. It is a slow-growing soft tissue tumor of low to intermediate grade. The risk of metastasis is low, but its likelihood of local recurrence is significant.
- 2 January 2025
- Published by Springer Nature in Cureus
- Vol. 17  (1) , e76786
Open AccessDermatofibrosarcoma Protuberans of the Breast: A Clinicopathological Study of a Rare Cutaneous Low-Grade Sarcoma
Background: Dermatofibrosarcoma protuberans (DFSP) of the breast is a rare entity. It is a slow-growing soft tissue tumor of low to intermediate grade. The risk of metastasis is low, but its likelihood of local recurrence is significant.
- Open Access
- 26 October 2024
- Published by Springer Nature in Cureus
- Vol. 16  (10)
Sensitivity and Predictive Value of the Frozen Section of Sentinel Lymph Node Biopsy in the Post-neoadjuvant Setting: Experience From a Tertiary Care Hospital in a Resource-Limited Country
- 26 October 2024
- Published by Springer Nature in Cureus
- Vol. 16  (10)
Open AccessSensitivity and Predictive Value of the Frozen Section of Sentinel Lymph Node Biopsy in the Post-neoadjuvant Setting: Experience From a Tertiary Care Hospital in a Resource-Limited Country
- 30 December 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 222, 107511
Comprehensive clinical overview of malignant pleural mesothelioma
- 30 December 2023
- Published by Elsevier in Respiratory Medicine
- Vol. 222, 107511
Comprehensive clinical overview of malignant pleural mesothelioma
- Open Access
- 1 June 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 107  (C) , 108325
Axillary synovial sarcoma recurrence involving brachial plexus, a rare case report from Pakistan
Introduction: Synovial sarcomas are rare tumors, and the incidence of axillary synovial sarcoma involving the brachial plexus has been reported as 2.9 % among all axillary soft tissue tumors. However, the recurrence of axillary synovial sarcomas has not been reported in literature. Case presentation: A 36-years-old Afghan female presented in Karachi, Pakistan with a history of persistently increasing, recurrent, right axillary mass for 6 months. Initially diagnosed as a spindle-cell tumor on excision in Afghanistan, she had received ifosfamide and doxorubicin, but the lesion recurred. On examination, it was a 5 × 6 cm, hard mass palpable in right axilla. After radiological work-up and a multidisciplinary team discussion, she underwent complete excision of the tumor with successful preservation of brachial plexus. The final diagnosis was reported as monophasic synovial sarcoma FNCLCC Grade 3. Discussion: Our patient presented with a recurrent right axillary synovial sarcoma that was involving the axillary neurovascular bundle and brachial plexus, which was initially diagnosed as a spindle cell sarcoma. Pre-operative core-needle biopsy was unable to provide a definitive diagnosis. MRI scan was useful in delineating the proximity of the neurovascular structures. Re -excision of the tumor was performed which is the mainstay of treatment for axillary synovial sarcomas, combined with radiotherapy depending on the disease grading, staging and patient factors. Conclusion: Axillary synovial sarcoma recurrence with involvement of the brachial plexus is an extremely rare presentation. Our patient was successfully managed through a multidisciplinary approach with complete surgical excision and preservation of the brachial plexus followed by adjuvant radiotherapy. Highlights:
- 1 June 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 107  (C) , 108325
Open AccessAxillary synovial sarcoma recurrence involving brachial plexus, a rare case report from Pakistan
Introduction: Synovial sarcomas are rare tumors, and the incidence of axillary synovial sarcoma involving the brachial plexus has been reported as 2.9 % among all axillary soft tissue tumors. However, the recurrence of axillary synovial sarcomas has not been reported in literature. Case presentation: A 36-years-old Afghan female presented in Karachi, Pakistan with a history of persistently increasing, recurrent, right axillary mass for 6 months. Initially diagnosed as a spindle-cell tumor on excision in Afghanistan, she had received ifosfamide and doxorubicin, but the lesion recurred. On examination, it was a 5 × 6 cm, hard mass palpable in right axilla. After radiological work-up and a multidisciplinary team discussion, she underwent complete excision of the tumor with successful preservation of brachial plexus. The final diagnosis was reported as monophasic synovial sarcoma FNCLCC Grade 3. Discussion: Our patient presented with a recurrent right axillary synovial sarcoma that was involving the axillary neurovascular bundle and brachial plexus, which was initially diagnosed as a spindle cell sarcoma. Pre-operative core-needle biopsy was unable to provide a definitive diagnosis. MRI scan was useful in delineating the proximity of the neurovascular structures. Re -excision of the tumor was performed which is the mainstay of treatment for axillary synovial sarcomas, combined with radiotherapy depending on the disease grading, staging and patient factors. Conclusion: Axillary synovial sarcoma recurrence with involvement of the brachial plexus is an extremely rare presentation. Our patient was successfully managed through a multidisciplinary approach with complete surgical excision and preservation of the brachial plexus followed by adjuvant radiotherapy. Highlights:
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 105  (C) , 107996
Skin reducing nipple sparing mastectomy with immediate breast reconstruction for huge borderline phyllodes tumor of the breast
Introduction: Borderline phyllodes tumors are very infrequent breast tumors encountered by surgeons. Case presentation: We present a case of a young woman with a very large borderline phyllodes tumor measuring 20 cm × 20 cm, involving almost all of the breast, causing gross asymmetry of the breasts. Discussion: The patient wished to maintain symmetry following the surgery as a result of which a simple mastectomy followed by implant based Immediate breast reconstruction was planned. The patient had an uneventful recovery postoperatively with equal breast size bilaterally. Conclusion: Implant based immediate breast reconstruction thus provides a comprehensive solution and excellent cosmesis for women with very large borderline phyllodes requiring mastectomy. Highlights:
- 1 April 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 105  (C) , 107996
Open AccessSkin reducing nipple sparing mastectomy with immediate breast reconstruction for huge borderline phyllodes tumor of the breast
Introduction: Borderline phyllodes tumors are very infrequent breast tumors encountered by surgeons. Case presentation: We present a case of a young woman with a very large borderline phyllodes tumor measuring 20 cm × 20 cm, involving almost all of the breast, causing gross asymmetry of the breasts. Discussion: The patient wished to maintain symmetry following the surgery as a result of which a simple mastectomy followed by implant based Immediate breast reconstruction was planned. The patient had an uneventful recovery postoperatively with equal breast size bilaterally. Conclusion: Implant based immediate breast reconstruction thus provides a comprehensive solution and excellent cosmesis for women with very large borderline phyllodes requiring mastectomy. Highlights:
- Open Access
- 4 August 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104295
Case report: Axilla fibroadenoma – An atypical presentation
Introduction: Fibroadenoma is the most common benign breast tumor among women between 15 and 35 years, however, a fibroadenoma arising from accessory breast tissue is a rare occurrence. Case presentation: We encountered this uncommon presentation in a 37 years old female with a gradually increasing left axillary lump associated with discomfort. On ultrasound it was a 17.3 mm x 10.6 mm x 17.5 mm well defined solid nodule with internal vascularity, BiRADS IVa lesion. Core biopsy revealed fibroepithelial lesion and the patient electively underwent excisional biopsy. Histopathology confirmed the diagnosis of fibroadenoma, which was completely excised. Clinical discussion: Approximately half of all breast lumps in women are diagnosed as fibroadenomas, making it the most common benign breast mass. Nonetheless, an axillary mass has several differentials such as lymphadenopathy, lipoma or sebaceous cyst, while a fibroadenoma developed from ectopic breast tissue in the axilla is an unusual condition. Masses in axilla like ectopic breast tissue are clinically significant as they undergo physiological changes like the normal breast tissue like pain and discomfort during pregnancy, lactation and menstruation. This tissue may also undergo pathological changes and may pose a diagnostic challenge. Conclusion: Axillary lumps pose a diagnostic dilemma and accessory breast tissue related pathologies should be considered.
- 4 August 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104295
Open AccessCase report: Axilla fibroadenoma – An atypical presentation
Introduction: Fibroadenoma is the most common benign breast tumor among women between 15 and 35 years, however, a fibroadenoma arising from accessory breast tissue is a rare occurrence. Case presentation: We encountered this uncommon presentation in a 37 years old female with a gradually increasing left axillary lump associated with discomfort. On ultrasound it was a 17.3 mm x 10.6 mm x 17.5 mm well defined solid nodule with internal vascularity, BiRADS IVa lesion. Core biopsy revealed fibroepithelial lesion and the patient electively underwent excisional biopsy. Histopathology confirmed the diagnosis of fibroadenoma, which was completely excised. Clinical discussion: Approximately half of all breast lumps in women are diagnosed as fibroadenomas, making it the most common benign breast mass. Nonetheless, an axillary mass has several differentials such as lymphadenopathy, lipoma or sebaceous cyst, while a fibroadenoma developed from ectopic breast tissue in the axilla is an unusual condition. Masses in axilla like ectopic breast tissue are clinically significant as they undergo physiological changes like the normal breast tissue like pain and discomfort during pregnancy, lactation and menstruation. This tissue may also undergo pathological changes and may pose a diagnostic challenge. Conclusion: Axillary lumps pose a diagnostic dilemma and accessory breast tissue related pathologies should be considered.
- Open Access
- 7 March 2022
- Published by Wiley in International Journal of Surgical Oncology
- Vol. 2022, 1-14
High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan
Oral squamous cell carcinoma (OSCC) is a top-ranked cancer in the Pakistani population, and patient survival has remained unchanged at ∼50% for several decades. Recent advances have claimed that a subset of tumour cells, called cancer stem cells (CSCs), are responsible for tumour progression, treatment resistance, and metastasis, which leads to a poor prognosis. This study investigated the impact of CSC markers expression on overall survival (OS) and disease-free survival (DFS) of OSCC patients. Materials and Methods. Immunohistochemistry was used to evaluate CD44, CD133, L1CAM, and SOX2 expression in a well-characterized cohort of 100 Pakistani patients with primary treatment naïve OSCC. The immunoreactivity for each marker was correlated with patient clinicopathologic characteristics, oral cancer risk chewing habits, and survival. The minimum follow-up time for all patients was five years, and survival estimates were calculated using the Kaplan–Meier method and Cox proportional hazards model. Results. In this cohort of 100 patients, there were 57 males and 43 females. The median OS and DFS time durations observed were 64 and 52.5 months, respectively. Positive expression for CD44, CD133, L1CAM, and SOX2 was observed in 33%, 23%, 41%, and 63% of patients. High CD44 expression correlated with decreased OS ( ) but did not influence DFS. However, CD133, L1CAM, and SOX2 had no effect on either OS or DFS. Tonsils, nodal involvement, and AJCC stage were independent predictors of worse OS and DFS both. Conclusion. Of the CSC markers investigated here, only CD44 was a predictor for poor OS. CD44 was also associated with advanced AJCC and T stages. Interestingly, CD133 was significantly lower in patients who habitually consumed oral cancer risk factors.
- 7 March 2022
- Published by Wiley in International Journal of Surgical Oncology
- Vol. 2022, 1-14
Open AccessHigh CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan
Oral squamous cell carcinoma (OSCC) is a top-ranked cancer in the Pakistani population, and patient survival has remained unchanged at ∼50% for several decades. Recent advances have claimed that a subset of tumour cells, called cancer stem cells (CSCs), are responsible for tumour progression, treatment resistance, and metastasis, which leads to a poor prognosis. This study investigated the impact of CSC markers expression on overall survival (OS) and disease-free survival (DFS) of OSCC patients. Materials and Methods. Immunohistochemistry was used to evaluate CD44, CD133, L1CAM, and SOX2 expression in a well-characterized cohort of 100 Pakistani patients with primary treatment naïve OSCC. The immunoreactivity for each marker was correlated with patient clinicopathologic characteristics, oral cancer risk chewing habits, and survival. The minimum follow-up time for all patients was five years, and survival estimates were calculated using the Kaplan–Meier method and Cox proportional hazards model. Results. In this cohort of 100 patients, there were 57 males and 43 females. The median OS and DFS time durations observed were 64 and 52.5 months, respectively. Positive expression for CD44, CD133, L1CAM, and SOX2 was observed in 33%, 23%, 41%, and 63% of patients. High CD44 expression correlated with decreased OS ( ) but did not influence DFS. However, CD133, L1CAM, and SOX2 had no effect on either OS or DFS. Tonsils, nodal involvement, and AJCC stage were independent predictors of worse OS and DFS both. Conclusion. Of the CSC markers investigated here, only CD44 was a predictor for poor OS. CD44 was also associated with advanced AJCC and T stages. Interestingly, CD133 was significantly lower in patients who habitually consumed oral cancer risk factors.
- Open Access
- 15 July 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15  (7) , e0009584
Gut integrity and duodenal enteropathogen burden in undernourished children with environmental enteric dysfunction
Environmental enteric dysfunction (EED) is a subclinical condition of intestinal inflammation, barrier dysfunction and malabsorption associated with growth faltering in children living in poverty. This study explores association of altered duodenal permeability (lactulose, rhamnose and their ratio) with higher burden of enteropathogen in the duodenal aspirate, altered histopathological findings and higher morbidity (diarrhea) that is collectively associated with linear growth faltering in children living in EED endemic setting. In a longitudinal birth cohort, 51 controls (WHZ > 0, HAZ > −1.0) and 63 cases (WHZ< -2.0, refractory to nutritional intervention) were recruited. Anthropometry and morbidity were recorded on monthly bases up to 24 months of age. Dual sugar assay of urine collected after oral administration of lactulose and rhamnose was assessed in 96 children from both the groups. Duodenal histopathology (n = 63) and enteropathogen analysis of aspirate via Taqman array card (n = 60) was assessed in only cases.Giardiawas the most frequent pathogen and was associated with raised L:R ratio (p = 0.068). Gastric microscopy was more sensitive than duodenal aspirate inH.pyloridetection. Microscopically confirmedH.pylorinegatively correlated with HAZ at 24 months (r = −0.313, p = 0.013). Regarding histopathological parameters, goblet cell reduction significantly correlated with decline in dual sugar excretion (p< 0.05). Between cases and controls, there were no significant differences in the median (25th, 75thpercentile) of urinary concentrations (μg/ml) of lactulose [27.0 (11.50, 59.50) for cases vs. 38.0 (12.0, 61.0) for controls], rhamnose [66.0 (28.0, 178.0) vs. 86.5 (29.5, 190.5)] and L:R ratio [0.47 (0.24, 0.90) vs. 0.51 (0.31, 0.71)] respectively. In multivariable regression model, 31% of variability in HAZ at 24 months of age among cases and controls was explained by final model including dual sugars. In conclusion, enteropathogen burden is associated with altered histopathological features and intestinal permeability. In cases and controls living in settings of endemic enteropathy, intestinal permeability test may predict linear growth. However, for adoption as a screening tool for EED, further validation is required due to its complex intestinal pathophysiology.
- 15 July 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15  (7) , e0009584
Open AccessGut integrity and duodenal enteropathogen burden in undernourished children with environmental enteric dysfunction
Environmental enteric dysfunction (EED) is a subclinical condition of intestinal inflammation, barrier dysfunction and malabsorption associated with growth faltering in children living in poverty. This study explores association of altered duodenal permeability (lactulose, rhamnose and their ratio) with higher burden of enteropathogen in the duodenal aspirate, altered histopathological findings and higher morbidity (diarrhea) that is collectively associated with linear growth faltering in children living in EED endemic setting. In a longitudinal birth cohort, 51 controls (WHZ > 0, HAZ > −1.0) and 63 cases (WHZ< -2.0, refractory to nutritional intervention) were recruited. Anthropometry and morbidity were recorded on monthly bases up to 24 months of age. Dual sugar assay of urine collected after oral administration of lactulose and rhamnose was assessed in 96 children from both the groups. Duodenal histopathology (n = 63) and enteropathogen analysis of aspirate via Taqman array card (n = 60) was assessed in only cases.Giardiawas the most frequent pathogen and was associated with raised L:R ratio (p = 0.068). Gastric microscopy was more sensitive than duodenal aspirate inH.pyloridetection. Microscopically confirmedH.pylorinegatively correlated with HAZ at 24 months (r = −0.313, p = 0.013). Regarding histopathological parameters, goblet cell reduction significantly correlated with decline in dual sugar excretion (p< 0.05). Between cases and controls, there were no significant differences in the median (25th, 75thpercentile) of urinary concentrations (μg/ml) of lactulose [27.0 (11.50, 59.50) for cases vs. 38.0 (12.0, 61.0) for controls], rhamnose [66.0 (28.0, 178.0) vs. 86.5 (29.5, 190.5)] and L:R ratio [0.47 (0.24, 0.90) vs. 0.51 (0.31, 0.71)] respectively. In multivariable regression model, 31% of variability in HAZ at 24 months of age among cases and controls was explained by final model including dual sugars. In conclusion, enteropathogen burden is associated with altered histopathological features and intestinal permeability. In cases and controls living in settings of endemic enteropathy, intestinal permeability test may predict linear growth. However, for adoption as a screening tool for EED, further validation is required due to its complex intestinal pathophysiology.